Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/133952
DC FieldValue
dc.titleVasorelaxation of rat thoracic aorta caused by 14-deoxyandrographolide
dc.contributor.authorZhang, C.Y.
dc.contributor.authorTan, B.K.H.
dc.date.accessioned2016-12-20T08:41:51Z
dc.date.available2016-12-20T08:41:51Z
dc.date.issued1998
dc.identifier.citationZhang, C.Y., Tan, B.K.H. (1998). Vasorelaxation of rat thoracic aorta caused by 14-deoxyandrographolide. Clinical and Experimental Pharmacology and Physiology 25 (6) : 424-429. ScholarBank@NUS Repository.
dc.identifier.issn03051870
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/133952
dc.description.abstract1. The pharmacological effects of 14-deoxyandrographolide on rat isolated thoracic aorta were examined. 2. 14-Deoxyandrographolide (2.5-120 μmo/L) inhibited contractions induced by phenylephrine (PE; 0.1 μmol/L) and high K + (80 mmol/L) in a concentration-dependent manner in endothelium- intact aorta. The effect was attenuated in endothelium-denuded aorta without modifying the maximal response. Like verapamil, 14-deoxyandrographolide produced a much greater vasorelaxant effect in aorta precontracted by KCl than by PE. 14-Deoxyandrographolide (20-60 μmol/L) also inhibited responses of the rat aorta to PE. 3. In Ca 2+-free medium (KCl 55 mmol/L), 14- deoxyandrographolide (20-80 μmol/L) antagonized Ca 2+-induced vasocontraction in a concentration-dependent manner and transient contractions induced by both caffeine (10 mmol/L) and noradrenaline (1 μmol/L) were suppressed or almost abolished by 14-deoxyandrographolide. 4. The vasorelaxant effect of 14-deoxyandrographolide was partially antagonized by N(G)-nitro-L-arginine methyl ester (25 μmol/L), a specific and competitive nitric oxide synthase (NOS) inhibitor, and methylene blue (10 μmol/L), a soluble guanylate cyclase inhibitor, but was not affected by indomethacin (20 μmol/L), a cyclo-oxygenase inhibitor, or glibenclamide (10 μmol/L), an ATP-sensitive K +-channel blocker. 5. These results suggest that the vasorelaxant activity of 14-deoxyandrographolide may be mediated via the activation of NOS and guanylate cyclase, as well as the blockade of Ca 2+ influx through both voltage- and receptor-operated Ca 2+ channels.
dc.subject14-Deoxyandrographolide
dc.subjectAorta
dc.subjectCa 2+ influx
dc.subjectNitric oxide
dc.subjectVasorelaxation
dc.typeArticle
dc.contributor.departmentPHARMACOLOGY
dc.description.sourcetitleClinical and Experimental Pharmacology and Physiology
dc.description.volume25
dc.description.issue6
dc.description.page424-429
dc.description.codenCEXPB
dc.identifier.isiutNOT_IN_WOS
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.